Merck & Co., Inc. (MRK) Cash flow statement
Top 11 of 21 line items reported by MRK · 250+ in the full API →
Merck & Co., Inc. (MRK) · Cash Flow Statement
Consolidated Statements of Cash Flows
Quarterly · In millions USD, except per-share data · Latest filed Nov 4, 2026 · FY ends Dec 31
| Three Months Ended | ||||||
|---|---|---|---|---|---|---|
Q3 2026 Sep 30, 2026 | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Trend | |
| Net Cash Flow from Operating Activities | $6,558 | $5,370 | $3,918 | $2,857 | $7,822 | |
| Net Income | 5,065 | (1,335) | (4,240) | 2,963 | 5,785 | |
| Net Cash Flow from Investing Activities | $(1,319) | $(5,602) | $(10,210) | $(11,201) | $(283) | |
| Capital Expenditures | -1,040 | -893 | -991 | -1,033 | -987 | |
| Other Investing Activities | -54 | -22 | -66 | -172 | (-129) | |
| Net Cash Flow from Financing Activities | $(2,432) | $1,762 | $(2,981) | $4,751 | $2,638 | |
| Common stock repurchased | -653 | -757 | -874 | -1,252 | -1,323 | |
| Dividends Paid | -2,099 | -2,144 | -2,105 | -2,018 | -2,031 | |
| Other financing activities | 73 | (270) | (80) | 58 | 17 | |
| Net Cash Flow | $2,761 | $1,493 | $(9,292) | $(3,570) | $10,187 | |
| Free Cash Flow | 5,518 | 4,477 | 2,927 | 1,824 | 6,835 | |
Quarterly figures are derived from year-to-date filed amounts.
10 more line items available via the API
Depreciation & AmortizationStock-Based CompensationPurchases of investmentsNet Debt Issued (Repaid)Total debt issuedShort-term debt issuedLong-term debt issuedTotal debt repaidShort-term debt repaidLong-term debt repaid